Management of Lipid-Rich Adrenal Adenoma <4 cm with Minimal Growth
This lipid-rich adenoma measuring 2.9 cm with minimal growth (3 mm over 3 months) does not require further follow-up imaging or functional testing. 1
Rationale for No Further Follow-Up
The 2023 CUA/AUA guidelines provide clear direction for this clinical scenario:
Benign non-functional adenomas <4 cm confirmed as lipid-rich on MRI do not require any additional imaging or functional testing. 1
The tumor growth of approximately 3 mm over 3 months falls well below the threshold for concern. Lesions growing <3 mm/year do not require further imaging follow-up or functional testing. 1
Even if this growth rate continued, it would only represent 12 mm/year, which still warrants consideration for surgery only when growth exceeds 5 mm/year after repeating functional work-up. 1
Initial Functional Testing Required (If Not Already Done)
Before discontinuing surveillance, ensure the following screening has been completed:
All patients with adrenal incidentalomas must be screened for autonomous cortisol secretion using 1 mg dexamethasone suppression testing. 1
Screening for pheochromocytoma is NOT needed in patients with unequivocal lipid-rich adenomas (HU <10 on CT or confirmed on MRI) who have no signs or symptoms of adrenergic excess. 1
If hypertension or hypokalemia is present, screen for primary aldosteronism with aldosterone-to-renin ratio. 1
Key Supporting Evidence
Prospective data confirms the safety of this approach: A 5-year follow-up study of lipid-rich adrenal incidentalomas <40 mm with <10 HU demonstrated mean tumor growth of only 1±2 mm, with no patients developing clinically relevant tumor growth or new subclinical hypercortisolism. 2 The largest tumor growth in that cohort was 8 mm over 5 years, which proved to be a benign cortical adenoma on surgical pathology. 2
Critical Pitfalls to Avoid
Do not continue surveillance imaging simply because the mass is present. The guidelines explicitly state no further follow-up is needed for confirmed benign adenomas <4 cm. 1, 3
Ensure the MRI truly confirms lipid-rich adenoma. Homogeneous signal intensity drop on chemical shift MRI is diagnostic of lipid-rich adenoma, while heterogeneous signal drop can occur in pheochromocytoma, adrenocortical carcinoma, and some metastases. 1
The 4 cm threshold is firm. If this lesion were ≥4 cm, repeat imaging in 6-12 months would be indicated even if radiologically benign. 1
When to Reconsider Imaging
Repeat imaging would only be warranted if:
The patient develops new symptoms suggesting hormone excess (Cushing's features, hypertension with hypokalemia, or adrenergic symptoms). 1
There is clinical suspicion for interval growth based on symptoms or physical examination changes. 1
Initial functional testing reveals mild autonomous cortisol secretion requiring annual clinical screening for metabolic comorbidities. 1